Precision AI Surgical Planning System (PAI-SPS)

The Precision AI Surgical Planning System (PAI-SPS) is designed to enhance shoulder joint arthroplasty by providing precise pre-surgical planning and accurate intraoperative guidance for implant placement. This is achieved by leveraging patient CT scan data to generate a 3D bone construct for virtual surgical planning via software, which then informs the manufacturing of patient-specific hardware to precisely transfer the plan to the operating room.

The Precision AI Surgical Planning System (PAI-SPS), a medical system for shoulder joint arthroplasty, has achieved market clearance after demonstrating substantial equivalence to a legally marketed predicate device. This clearance allows its commercialization for prescription use in adult patients undergoing total or reverse shoulder replacement procedures, subject to standard regulatory controls including annual registration, device listing, good manufacturing practices, and labeling adherence. The PAI-SPS integrates both software and patient-specific hardware components. Its pre-surgical planning software processes patient CT scan images to generate a 3D bone construct of the shoulder joint, allowing surgeons to visualize, measure, and virtually plan the optimal placement of artificial implants. This planning data is then utilized to design and manufacture the hardware, comprising patient-specific guides and biomodels, which are crucial for precisely transferring the pre-surgical plan to the operating room and assisting in accurate intraoperative positioning of shoulder implant components. An updated version of the system enhances its utility by expanding compatibility with a broader array of commercially available shoulder implant systems.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the PAI-SPS compare to traditional planning methods in terms of surgical accuracy and patient outcomes?; What specific parameters or metrics does the PAI-SPS software use to determine optimal implant placement?; Are there any long-term follow-up studies on patients who have undergone shoulder arthroplasty using the PAI-SPS, especially regarding implant longevity or complication rates?; What is the learning curve for surgeons utilizing the PAI-SPS, and what training is provided?; How does the expanded compatibility with a wider range of implant systems affect the validation and accuracy of the planning?